Jefferies maintained its Buy rating on Legend Biotech Corp . (NASDAQ:LEGN) but reduced the stock's price target from $94.00 to $91.00. The adjustment follows reports of Johnson & Johnson's $334 ...
Lorraine Kelly has opened up about her struggles with confidence and admits she feels 'working class cringe' despite being on ...
This four-time Emmy award winner, First Coast News anchor and mom has devoted countless hours to investigating and reporting local news stories. With her segment “Unsolved” leading to the solving of a ...
Jefferies reaffirmed its positive stance on Praxis Precision Medicines Inc . (NASDAQ:PRAX), maintaining a Buy rating and a price target of $305.00. The stock, currently valued at $1.54 billion market ...